Company Beijing Hotgen Biotech Co., Ltd.
Equities
688068
CNE100003P82
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.85 CNY | +1.08% | +4.96% | -27.28% |
29/04 | Beijing Hotgen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
16/04 | Beijing Hotgen Biotech to Buy Kaijing Gene Technology for 11 Million Yuan | MT |
Business Summary
Sales per Business
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Diagnostic Test Agent
98.9
%
| 5,280 | 98.3 % | 3,517 | 98.9 % | -33.40% |
Other Business
0.7
%
| 63 | 1.2 % | 24 | 0.7 % | -61.04% |
Diagnostic Instrument Device
0.3
%
| 18 | 0.3 % | 12 | 0.3 % | -36.67% |
Biogenic Materials
0.1
%
| 8 | 0.1 % | 4 | 0.1 % | -51.77% |
Sales per region
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Overseas
62.2
%
| 5,063 | 95.4 % | 2,197 | 62.2 % | -56.61% |
China
37.8
%
| 243 | 4.6 % | 1,335 | 37.8 % | +449.16% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chang Qing Lin
CEO | Chief Executive Officer | 48 | 23/05/23 |
Jing Li
CHM | Chairman | 46 | 01/06/01 |
Yong Zhan Shi
DFI | Director of Finance/CFO | 42 | 01/15/01 |
Yong Qiao
CTO | Chief Tech/Sci/R&D Officer | 41 | 01/13/01 |
Qi Gao
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/13/01 |
Yan Zhao Li
BRD | Director/Board Member | 41 | 01/23/01 |
Xiao Li Liu
BRD | Director/Board Member | 47 | 01/13/01 |
Shao Hua Yu
BRD | Director/Board Member | 45 | 01/05/01 |
Wei Min
PRN | Corporate Officer/Principal | 40 | 01/10/01 |
Hong Rui Zhang
PRN | Corporate Officer/Principal | 38 | 01/12/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chang Qing Lin
CEO | Chief Executive Officer | 48 | 23/05/23 |
Xin Zhou
BRD | Director/Board Member | 62 | 01/15/01 |
Shao Hua Yu
BRD | Director/Board Member | 45 | 01/05/01 |
Qing Feng Wang
BRD | Director/Board Member | 50 | 01/16/01 |
Shen Qi
BRD | Director/Board Member | 53 | 01/18/01 |
Yan Rong Hong
BRD | Director/Board Member | 49 | 01/16/01 |
Qi Gao
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/13/01 |
Xiao Li Liu
BRD | Director/Board Member | 47 | 01/13/01 |
Yun Feng Song
BRD | Director/Board Member | 54 | 01/22/01 |
Yan Zhao Li
BRD | Director/Board Member | 41 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 92,268,766 | 56,346,643 ( 61.07 %) | 286,147 ( 0.3101 %) | 61.07 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
2,643,924 | 2.87% | 11,179,357 $ |
Company contact information
Beijing Hotgen Biotech Co., Ltd.
Bldg 10, Hi-end Med Device Indl Park Zhongguancun
102600, Beijing
+
http://www.hotgen.com.cnSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-27.28% | 369M | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.8B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.66% | 26.59B | |
+3.21% | 26.78B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- 688068 Stock
- Company Beijing Hotgen Biotech Co., Ltd.